(Q43812054)

27 November 2017

title

The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population (English)

1 reference

27 November 2017

1 reference

Norma Torres-Carrillo

1

1 reference

27 November 2017

Heriberto Ontiveros-Mercado

2

1 reference

27 November 2017

Nora Magdalena Torres-Carrillo

3

1 reference

27 November 2017

Isela Parra-Rojas

4

1 reference

27 November 2017

Héctor Rangel-Villalobos

5

1 reference

27 November 2017

María Guadalupe Ramírez-Dueñas

6

1 reference

27 November 2017

Sergio Ramón Gutiérrez-Ureña

7

1 reference

27 November 2017

Yeminia Valle

8

1 reference

27 November 2017

José Francisco Muñoz-Valle

9

1 reference

27 November 2017

publication date

1 January 2013

1 reference

Cell Biochemistry and Biophysics

27 November 2017

published in

1 reference

27 November 2017

volume

67

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

1217-1228

1 reference

Genetics of rheumatoid arthritis: what have we learned?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Recent developments in the immunobiology of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

The role of T cells in rheumatoid arthritis: new subsets and new targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Cells of the synovium in rheumatoid arthritis. T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

The role of CTLA-4 in immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

HLA , CTLA-4 and PTPN22 : the shared genetic master-key to autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

A native soluble form of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Genetic insights into disease mechanisms of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Distribution of --844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

The +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

X-chromosomal markers: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Mechanisms of translational control by the 3' UTR in development and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

CTLA4 is differentially associated with autoimmune diseases in the Dutch population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9640-6

10.1007/S12013-013-9640-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1002063228

0 references

Fatcat ID

release_7fuo3kees5cnfgnkdhiplzviri

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7fuo3kees5cnfgnkdhiplzviri

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference